Efficacy and safety of anticoagulant treatment using New oral anticoagulant (edoxaban) in atrial fibrillation after cardiac surgery.
Phase of Trial: Phase II
Latest Information Update: 18 Jan 2018
At a glance
- Drugs Edoxaban (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 17 Jan 2018 Status changed from recruiting to completed.
- 31 May 2016 New trial record